Major Wall Street analysts recently revised their outlooks on several prominent companies, signaling a shift in investment sentiment. These changes, occurring on May 29, 2026, include downgrades for Boston Scientific Corp, Gap Inc, and Equity Residential, reflecting new expert evaluations of their market positions and future prospects.
Analyst Revisions for Key Companies on May 29, 2026
On May 29, 2026, significant adjustments in stock ratings were announced by leading financial analysts for three major corporations, drawing considerable attention from the investment community.
Wolfe Research's expert, Mike Polark, revised his rating for Boston Scientific Corp (NYSE: BSX) from an 'Outperform' to a 'Peer Perform'. This modification suggests a more tempered expectation for the medical technology company's future performance relative to its industry peers. At the close of trading on the preceding Thursday, Boston Scientific shares were valued at $49.11.
Meanwhile, Michael Binetti, an analyst at Evercore ISI Group, downgraded Gap Inc (NYSE: GAP) from an 'Outperform' to an 'In-Line' rating. Accompanying this downgrade, Binetti also reduced the price target for the apparel retailer from $28 to $20. This indicates a more cautious stance on Gap's growth trajectory and market valuation. Gap shares ended Thursday's trading session at $25.00.
In the real estate sector, Alexander Goldfarb of Piper Sandler moved Equity Residential (NYSE: EQR) from an 'Overweight' to a 'Neutral' rating. Furthermore, Goldfarb adjusted the price target for the residential REIT from $78 to $72. This re-evaluation points to a belief that Equity Residential's stock may now be fairly valued, with less upside potential than previously anticipated. Equity Residential shares closed at $66.26 on Thursday.
These collective downgrades from esteemed analysts highlight a critical moment for investors to reassess their positions in these companies, as expert opinions signal potential headwinds or a re-calibration of expected returns across different sectors.
These analyst downgrades serve as a vital reminder of the dynamic nature of financial markets and the importance of continuous evaluation. Investors should view these revised ratings as a prompt to conduct their own due diligence, considering various factors beyond a single analyst's report. The adjustments in price targets and ratings underscore the ongoing need for a comprehensive understanding of market sentiment, company fundamentals, and broader economic conditions when making investment decisions. Such shifts highlight that even well-established companies can face re-evaluations, emphasizing the need for adaptability and informed strategy in investment portfolios.
